Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection

Sunil Palani, Shruti Bansal, Atul K. Verma, Christopher Bauer, Shengjun Shao, Md Bashir Uddin and Keer Sun
J Immunol July 1, 2022, 209 (1) 128-135; DOI: https://doi.org/10.4049/jimmunol.2101135
Sunil Palani
*Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sunil Palani
Shruti Bansal
†Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atul K. Verma
*Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Bauer
†Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher Bauer
Shengjun Shao
*Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Md Bashir Uddin
*Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Md Bashir Uddin
Keer Sun
*Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX; and
†Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Key Points

  • IFN-γ plays a dominant role in the deterioration of IAV/bacterial coinfection.

  • IFN-γ induces alveolar macrophage depletion during IAV/bacterial coinfection.

  • IFN-α/β signaling prevents IFN-γ hyperproduction during IAV/bacterial coinfection.

Abstract

Postinfluenza bacterial pneumonia is a significant cause of hospitalization and death in humans. The mechanisms underlying this viral and bacterial synergy remain incompletely understood. Recent evidence indicates that influenza-induced IFNs, particularly type I IFN (IFN-I) and IFN-γ, suppress antibacterial defenses. In this study, we have investigated the relative importance and interplay of IFN-I and IFN-γ pathways in influenza-induced susceptibility to Streptococcus pneumoniae infection. Using gene-deficient mouse models, as well as in vivo blocking Abs, we show that both IFN-I and IFN-γ signaling pathways contribute to the initial suppression of antibacterial immunity; however, IFN-γ plays a dominant role in the disease deterioration, in association with increased TNF-α production and alveolar macrophage (AM) depletion. We have previously shown that IFN-γ impairs AM antibacterial function and thereby acute bacterial clearance. The findings in this study indicate that IFN-γ signaling also impairs AM viability and αβ T cell recruitment during the progression of influenza/S. pneumoniae coinfection. Macrophages insensitive to IFN-γ mice express a dominant-negative mutant IFN-γR in mononuclear phagocytes. Interestingly, macrophages insensitive to IFN-γ mice exhibited significantly improved recovery and survival from coinfection, despite delayed bacterial clearance. Importantly, we demonstrate that IFN-I receptor signaling is essential for preventing IFN-γ hyperproduction and animal death during the progression of postinfluenza pneumococcal pneumonia.

Footnotes

  • This work was supported by US Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant R01 HL118408 (to K.S.) and HHS, NIH, National Institute of Allergy and Infectious Diseases Grant R21 AI128527 (to K.S.).

  • Abbreviations used in this article:

    AM
    alveolar macrophage
    BALF
    bronchoalveolar lavage fluid
    dps
    days after SPn superinfection
    IAV
    influenza A virus
    IFN-I
    type I IFN
    i.n.
    intranasally
    LDH
    lactate dehydrogenase
    MIIG
    macrophages insensitive to IFN-γ
    PR8
    A/Puerto Rico/8/1934
    SPn
    S. pneumoniae serotype 14 strain TJO983
    UNMC
    University of Nebraska Medical Center
    UTMB
    University of Texas Medical Branch
    WT
    wild-type

  • Received December 1, 2021.
  • Accepted April 27, 2022.
  • Copyright © 2022 by The American Association of Immunologists, Inc.
View Full Text

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

In this issue

The Journal of Immunology: 209 (1)
The Journal of Immunology
Vol. 209, Issue 1
1 Jul 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection
Sunil Palani, Shruti Bansal, Atul K. Verma, Christopher Bauer, Shengjun Shao, Md Bashir Uddin, Keer Sun
The Journal of Immunology July 1, 2022, 209 (1) 128-135; DOI: 10.4049/jimmunol.2101135

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection
Sunil Palani, Shruti Bansal, Atul K. Verma, Christopher Bauer, Shengjun Shao, Md Bashir Uddin, Keer Sun
The Journal of Immunology July 1, 2022, 209 (1) 128-135; DOI: 10.4049/jimmunol.2101135
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Duck CD8+ T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro
  • Arid5a Mediates an IL-17–Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense
  • Akt-2 Is a Potential Therapeutic Target for Disseminated Candidiasis
Show more INFECTIOUS DISEASE AND HOST RESPONSE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606